ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. Predicting Outcomes in Community-Acquire…

Predicting Outcomes in Community-Acquired Pneumonia

CHEST·August 10
Respiratory SystemPractice changingCommunity-Acquired PneumoniaSevere Community-Acquired PneumoniaEditorialBiomarkerComplete Blood CountAdult

Summary

View source

What was studied

This editorial reviews evidence on admission eosinopenia (≤10 cells/μL) as a predictor of outcomes in hospitalized patients with community-acquired pneumonia (CAP), commenting on a linked multicenter prospective study (Weckler et al, CAPNETZ cohort) and synthesizing findings from related studies.

Key findings

Admission eosinopenia (≤10 cells/μL) was independently associated with ICU admission, need for mechanical ventilation, and longer hospital stay in CAP; it did not predict 30-day mortality in the general CAP cohort (overall mortality ~9%), but in severe CAP (ICU-admitted patients, n=496), eosinopenia (≤50 cells/μL) was an independent predictor of 30-day death (HR 1.95; 95% CI 1.19–3.20; P=.0008). Combined eosinopenia and lymphopenia showed additive predictive value for resource utilization.

Study limitations

This is an editorial, not a primary study — conclusions are synthesized from multiple studies with differing eosinopenia thresholds (≤10 vs ≤50 cells/μL), making direct comparisons difficult. The relatively low overall mortality in the CAPNETZ cohort (~9%) may limit detection of a mortality signal. Authors call for prospective multicenter trials to confirm these findings.

Clinical implications

Check a simple blood count eosinophil level at admission in CAP patients — eosinopenia (≤10 cells/μL) flags higher risk of ICU admission and mechanical ventilation and can guide resource planning. Rising eosinophil counts during recovery may signal clinical improvement, consistent with the concept of 'dawn of well-being.'

Related Questions

Explore related topics

Which clinical scoring tools best predict mortality in community-acquired pneumonia?What scoring tools best predict severity in community-acquired pneumonia?What eosinophil count threshold best predicts ICU admission in community-acquired pneumonia?How does PSI compare to CURB-65 for risk stratification in community-acquired pneumonia?How does PSI compare to CURB-65 for community-acquired pneumonia risk stratification?How do eosinopenia and lymphopenia together affect outcomes in hospitalized CAP patients?Which patients with community-acquired pneumonia need ICU-level care?Can rising eosinophil counts during treatment indicate recovery in pneumonia patients?What factors predict ICU admission or treatment failure in community-acquired pneumonia?

Publication Details

Year
2026
Journal
CHEST
Source
View article
Keep scrolling
More content below.
Up Next